CoChat

Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia‐bearing mice

Open access
Pessina, Augusto, Coccè, Valentina, Pascucci, Luisa, Bonomi, Arianna, Cavicchini, Loredana, Sisto, Francesca, Ferrari, Maura, Ciusani, Emilio, Crovace, Antonio, Falchetti, Maria Laura, Zicari, Sonia, Caruso, Arnaldo, Navone, Stefania, Marfia, Giovanni, Benetti, Anna, Ceccarelli, Piero, Parati, Eugenio, Alessandri, Giulio · 2013 · British Journal of Haematology
Cited by 84

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Summary: Current leukaemia therapy focuses on increasing chemotherapy efficacy. Mesenchymal stromal cells (MSC s) have been proposed for carrying and delivery drugs to improve killing of cancer cells. We have shown that MSC s loaded with Paclitaxel (PTX) acquire a potent anti‐tumour activity. We investigated the effect of human MSC s (hMSC s) and mouse SR 4987 loaded with PTX (hMSCsPTX and SR 4987 PTX) on MOLT‐4 and L 1210, two leukaemia cell (LCs) lines of human and mouse origin, respectively. SR 4987 PTX and hMSCsPTX showed strong anti‐LC activity. hMSCsPTX, co‐injected with MOLT‐4 cells or intra‐tumour injected into established subcutaneous MOLT‐4 nodules, strongly inhibited growth and angiogenesis. In BDF 1‐mice‐bearing L 1210, the intraperitoneal administration of SR 4987 PTX doubled mouse survival time. In vitro, both hMSC s and hMSCsPTX released chemotactic factors, bound and formed rosettes with LC s. In ultrastructural analysis of rosettes, hMSCsPTX showed no morphological alterations while the attached LC s were apoptotic and necrotic. hMSC s and hMSCsPTX released molecules that reduced LC adhesion to microvascular endothelium (hMEC s) and down‐modulated ICAM 1 and VCAM 1 on hMEC s. Priming hMSC s with PTX is a simple procedure that does not require any genetic cell manipulation. Once the effectiveness of hMSCsPTX on established cancers in mice is proven, this procedure could be proposed for leukaemia therapy in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bjh.12196

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 84

Metadata

Authors
Pessina, A., Coccè, V., Pascucci, L., Bonomi, A., Cavicchini, L., Sisto, F., Ferrari, M., Ciusani, E., Crovace, A., Falchetti, M. L., Zicari, S., Caruso, A., Navone, S., Marfia, G., Benetti, A., Ceccarelli, P., Parati, E., & Alessandri, G.
Venue
British Journal of Haematology
Publisher
Wiley
Published
2013-01-07
Volume
160
Issue
6
Pages
766-778
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W2139092985
Cited by
84
References
6
FWCI
2.22
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia‐bearing mice. https://app.cochat.ai/papers/10.1111/bjh.12196
The paper
Pessina, A., Coccè, V., Pascucci, L., Bonomi, A., Cavicchini, L., Sisto, F., Ferrari, M., Ciusani, E., Crovace, A., Falchetti, M. L., Zicari, S., Caruso, A., Navone, S., Marfia, G., Benetti, A., Ceccarelli, P., Parati, E., & Alessandri, G. (2013). Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia‐bearing mice. British Journal of Haematology. https://doi.org/10.1111/bjh.12196

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.